´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2.
NCT ID: NCT04092738
Last Updated: 2019-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
368 participants
INTERVENTIONAL
2019-03-04
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)
NCT04219800
Monocular-Camera-Based Mobile Exergame for Type 2 Diabetes Prevention
NCT06950528
Effect of Monitoring of Step Number on Diabetes
NCT03407222
Effectiveness of a Multifactorial Intervention to Improve Diet and Physical Activity in Diabetics From Primary Care
NCT02991079
App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes
NCT03053336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention: A mHealth program (13 wks) will progressively replace occupational sitting time with light physical activities. Participants from the CG will receive usual care. Multivariate analysis will assess changes over time (post intervention and at 6 months follow up) in the dependent variables; looking at differences between groups. Intention to treat will be applied.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
In the intervention group, subjects will receive brief advice on occupational physical activity, sedentary behaviour and Diabetes Type 2. In addition, participants will be provided with an external movement sensor that will be linked to the Walk@WalkApp-Diab for Android and iOS. This App will monitor the time participants spend sitting, walking and standing during working hours. It will also provide participants with strategies to "sit less and move more" at work throughout 13 weeks. This mHealth intervention aims to change occupational sitting by replacing desk-based activities by active tasks.
Walk@WorkApp-Diab
The intervention (Walk@WorkApp-Diab), based on an mHealth program, consists on replacing sedentary job tasks for active ones, during 13 weeks. The intervention group will download the mHealth program into their personal cellphones
Control Group
Subjects will receive brief advice on occupational physical activity, sedentary behaviour and Diabetes Type 2.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walk@WorkApp-Diab
The intervention (Walk@WorkApp-Diab), based on an mHealth program, consists on replacing sedentary job tasks for active ones, during 13 weeks. The intervention group will download the mHealth program into their personal cellphones
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Doing sedentary tasks during at least a 55% of their daily work schedule (according to the Occupational Sedentary and Physical Activity Questionnaire: OSPAQ \>55%).
* Having a cellphone .
* Having a minimum work contract of 18.5 hours per week.
* Being able to get up from the chair or to walk by themselves (without any help).
Exclusion Criteria
* Having some pathology/disability/injury which changes their ability and capacity to walk or getting up from the chair.
* Doing less than a 55% of the daily tasks in a sitting position according to the OSPAQ questionnaire.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Salud Carlos III
OTHER_GOV
Consorci Hospitalari de Vic
OTHER
Institut Català de la Salut
OTHER
University of Vic - Central University of Catalonia
OTHER
Puerta de Hierro University Hospital
OTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Puig Ribera
Role: PRINCIPAL_INVESTIGATOR
Universitat de Vic
Carlos Martin Cantera
Role: STUDY_CHAIR
Jordi Gol i Gurina Foundation - IDIAP Jordi Gol
Francesc Alòs Colomer
Role: STUDY_CHAIR
Catalan Institute of Health
Mercè Solà Gonfaus
Role: STUDY_CHAIR
Catalan Institute of Health
Ana Urpí Fernández
Role: STUDY_CHAIR
Catalan Institute of Health
Josep Maria Molina Aragonés
Role: STUDY_CHAIR
Catalan Institute of Health
Blanca Funollet Santos
Role: STUDY_CHAIR
Catalan Institute of Health
Laura Illamola Martin
Role: STUDY_CHAIR
EAP Dreta de l'Eixample S.L.P
Ignasi Saigí Ullastre
Role: STUDY_CHAIR
Consorci Hospitalari de Vic (CHV)
Emi Chirveches-Pérez
Role: STUDY_CHAIR
Consorci Hospitalari de Vic (CHV)
Montserrat Martín-Horcajo
Role: STUDY_CHAIR
Universitat de Vic-Universitat Central de Catalunya (UVIC-UCC)
Montserrat Munuera Grau
Role: STUDY_CHAIR
Catalan Institute of Health
Miguel Brito
Role: STUDY_CHAIR
Madrid Health Service
David Pérez Manchon
Role: STUDY_CHAIR
Madrid Health Service
María Lorena López Catañon
Role: STUDY_CHAIR
Madrid Health Service
Montserrat Solís Muñoz
Role: STUDY_CHAIR
Madrid Health Service
Judit Bort-Roig
Role: STUDY_CHAIR
University of Vic - Central University of Catalonia
Mireia Félez-Nóbrega
Role: STUDY_CHAIR
Parc Sanitari Sant Joan de Déu (Sant Boi de Llobregat)
Francesc Garcia Cuyàs
Role: STUDY_CHAIR
Hospital Sant Joan de Déu (Barcelona)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IDIAP Jordi Gol
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alos F, Colomer MA, Bort-Roig J, Martin-Cantera C, Minaya A, Saigi I, Sitjar-Suner M, Puig-Ribera A. Impact of a primary care-based mobile health intervention to 'sit less and move more' on HbA1c, blood pressure, and other clinical outcomes in office employees with type 2 diabetes: A randomized controlled trial. Prim Care Diabetes. 2025 Oct;19(5):434-445. doi: 10.1016/j.pcd.2025.05.010. Epub 2025 Jun 9.
Alos F, Colomer MA, Martin-Cantera C, Solis-Munoz M, Bort-Roig J, Saigi I, Chirveches-Perez E, Sola-Gonfaus M, Molina-Aragones JM, Puig-Ribera A. Effectiveness of a healthcare-based mobile intervention on sedentary patterns, physical activity, mental well-being and clinical and productivity outcomes in office employees with type 2 diabetes: study protocol for a randomized controlled trial. BMC Public Health. 2022 Jun 29;22(1):1269. doi: 10.1186/s12889-022-13676-x.
Bort-Roig J, Chirveches-Perez E, Garcia-Cuyas F, Dowd KP, Puig-Ribera A. Monitoring Occupational Sitting, Standing, and Stepping in Office Employees With the W@W-App and the MetaWearC Sensor: Validation Study. JMIR Mhealth Uhealth. 2020 Aug 4;8(8):e15338. doi: 10.2196/15338.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI17/01788
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.